Painting the Colon: Early Stage Cancer Detection without Biopsy
Most cases of colon cancer begin as small noncancerous polyps. Over time these polyps may become colon cancers. Regular screening helps identify polyps before they […]
Month: March 2008
New Insurance Contracts for I-Flow’s ON-Q
I-Flow Corporation develops ambulatory drug delivery systems for pain management and infusion therapy. The company’s line of compact and portable infusion pumps includes catheters and […]
[Video Profile] Interview with Ron Andrews, President & CEO of Clarient
Clarient provides access to technologies and services for the characterization, assessment and treatment of cancer. The company offers a full range of diagnostic technologies and […]
Chembio Reports Fourth Quarter and Full-Year Results
Chembio Diagnostics reported financial results for the three and twelve months ended December 31, 2007. Total revenues for 2007 were $9.2 million, an increase of […]
Pieces Falling into Place for Harvest Technologies’ Bone Marrow Aspirate Concentrate System
Osteotech has signed an exclusive U.S. distribution agreement with Harvest Technologies, a privately held company based in Plymouth, MA, for its Bone Marrow Aspirate Concentrate […]
Hacking the Heart
A team of computer security researchers have remotely hacked Medtronic’s Maximo – a stopwatch-sized implantable cardiac defibrillator. Armed with an antenna, radio hardware and a […]
C. R. Bard to Acquire Specialized Health Products
Safety medical products manufacturer Specialized Health Products International (SHPI) will be acquired by C.R. Bard for $68.4 million in cash, or $1.00 per share. The […]
AngioDynamics Shares Tumble
Back in January, AngioDynamics affirmed its outlook for fiscal 2008, predicting net sales in the range of $170-$175 million. But on Friday, the company revised […]
[Video Profile] Interview with Jon Garfield, CEO of Clearant
Orthopedic tissue market is large and growing Technological advancements in the repair and replacement of damaged bone and soft tissue has driven the growth of […]
Nuvasive: Expect Big Things
NuVasive, a developer of surgical spine treatments, will offer $200 million convertible senior notes due 2013. The company estimates that the net proceeds from the […]